Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Pentamidine

SKU: orb1219669

Description

Pentamidine is an antifungal and antiprotozoal agent, interacting directly with the pathogen genome by binding to AT-rich regions of duplex DNA and the minor groove of DNA, thereby interfering with DNA replication.Pentamidine is effective in therapy for the hemolymphatic stage of Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number100-33-4
MW340.42
Purity>98% (HPLC)
FormulaC19H24N4O2
SMILESNC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(N)=N)cc1
TargetAntifungal

Bioactivity

In Vivo
Pentamidine (0.25 mg/mouse; intramuscular injection; every 2 days; for 4 weeks; athymic nude mice) treatment markedly inhibits the growth of WM9 human melanoma tumors in nude mice. Animal model: Athymic nude mice (6 weeks old) injected with WM9 cells. Dosage: 0.25 mg/mouse. Administration: Intramuscular injection; every 2 days; for 4 weeks. Result: Markedly inhibited the growth of WM9 human melanoma tumors in nude mice.
In Vitro
Pentamidine (0-10 μg/mL; 6 days; WM9, DU145, C4-2, Hey, WM480, and A549 cells) treatment inhibits the growth of cancer cells in a concentration-dependent manner. The cytotoxic properties of Pentamidine isethionate towards the promastigotes of the protozoan parasite Leishmania infantum is determined. The leishmanicidal activity of Pentamidine isethionate is 60 times higher after 72 h of incubation than that of Cisplatin. Pentamidine isethionate induces a higher amount of programmed cell death (PCD) than Cisplatin, which is associated with inhibition of DNA synthesis and cell-cycle arrest in the G2/M phase. Binding of Pentamidine isethionate to calf-thymus DNA (CT-DNA) induces conformational changes in the DNA double helix, consistent with a B-->A transition. The interaction of Pentamidine isethionate with ubiquitin leads to a 6% increase in the beta-sheet content of the protein. Cell Viability Assay Cell line: WM9, DU145, C4-2, Hey, WM480, and A549 cells. Concentration: 0-10 μg/mL. Incubation time: 6 days. Result: The growth of all six of the cell lines in culture was inhibited in a concentration-dependent manner with complete growth inhibition of the cell lines occurring at 10 μg/mL.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Pentamidine dimesylate [orb1699672]

    6823-79-6

    436.53

    C20H28N4O5S

    50 mg, 100 mg, 25 mg
  • Heptamidine [orb1709484]

    94345-47-8

    368.47

    C21H28N4O2

    50 mg, 100 mg, 25 mg
  • Heptamidine dimethanesulfonate [orb1309580]

    97.80% (May vary between batches)

    161374-55-6

    560.68

    C23H36N4O8S2

    1 ml x 10 mM (in DMSO), 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg
  • PNT1 Antibody [orb848650]

    ELISA,  WB

    Bacteria

    Rabbit

    Polyclonal

    Unconjugated

    2 mg
  • Pentamidine [orb1305716]

    98.13% (May vary between batches)

    100-33-4

    340.42

    C19H24N4O2

    5 mg, 200 mg, 500 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

5 mg
$ 100.00
200 mg
$ 440.00
500 mg
$ 820.00